DUBLIN--(BUSINESS WIRE)--The "Global Cancer vaccines market - segmented by type, technology, end-user and geography (2016 - 2021)" report has been added to Research and Markets' offering.
Analysts forecast the global cancer vaccines market to grow at a CAGR of 12-18% over the period 2015-2020.
The market for cancer vaccines is much smaller than other cancer therapeutic categories. The size of the market can be attributed to the nascent stages of industry life cycle and the late introduction of the vaccines in the market. To tap this market, many global companies are actively investing in cancer vaccine development. The market penetration is expected to increase with the increase in competition among the various pharmaceutical companies to obtain a larger portion of this market.
Key Market Drivers:
- Increasing cancer cases
- Technological developments
- Drug innovations with regard to the cancer
- Government initiatives
- Rise in aging populace
- Advanced health care services
- Upsurge in awareness about cancer and their available therapies in the market
- Increasing health care expenditure
Companies Mentioned:
- AstraZeneca plc
- Aduro BioTech
- Cytos
- Galena Biopharma
- Juvaris Biotherapeutics
- MedImmune
- Oxford BioMedica
- Prima BioMed
- GlaxoSmithKline
- Sanofi
- Merk&co
- Ubivac
- Vaccinogen
Key Topics Covered:
1. Executive Summary
2. Research Methodology
3. Introduction
4. Market Overview
5. Porters Five Force Analysis
6. Market Segmentation
7. Competitive Landscape
8. Company Profiles
9. Appendix
For more information about this report visit https://www.researchandmarkets.com/research/bb38jz/global_cancer
